Purchases and Sales Made in Q4 2024 in Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA) during Q4 2024. The information is specifically focused on institutions that hold shares of Innate Pharma SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
470+ 229.27% |
$677 - $1.42K
|
675
$1.43K
|
|
|
Feb 12, 2025
Q4 2024
|
National Bank Of Canada
|
BUY
|
- |
450New |
$648 - $1.36K
|
450
$954
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
SELL
|
- |
-4.9K- 58.25% |
$7.05K - $14.8K
|
3.51K
$7.44K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-9.41K- 44.27% |
$13.6K - $28.4K
|
11.9K
$25.1K
|
|
|
Feb 14, 2025
Q4 2024
|
Optiver Holding B.V.
Amsterdam, P7 |
SELL
|
- |
-86.7K- 99.88% |
$125K - $262K
|
101
$214
|